chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine serious 04/01, MODERNA, dose #1 05/01, MODERNA, dose #2 12/27 COVID swab, result: detected 12/23 pt cc: chills, cough, fatigue, fever, headache, myalgias, rhinorrhea, dyspnea, sore throat exposure: unknown
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time normal, Ageusia, Anosmia, Blood fibrinogen increased, Brain natriuretic peptide increased
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/25, Pfizer, dose #1 04/16, Pfizer, dose #2 11/05, Pfizer, dose #3 12/26 COVID swab, result: detected 12/23 pt cc: cough, fatigue, headache, loss of taste or smell, myalgias, rhinorrhea, sore throat exposure: unknown 12/26 pt medicine cc: cough sob dx: Covid Pneumonia LOS: 4 days APTT 35.2 12/26 SARS-COV-2 Variant Sequencing: pending 12/26 CXR impression: No acute cardiopulmonary disease. 12/26 INR; 1.11 12/26 DDIMER: 0.41 12/26 PT: 12.4 12/26 12/26 BNP: 104.8 12/27 FIBRINOGEN: 596 12/27 DDIMER: 0.26 12/27 PROCALCITONIN: <0.05 12/27 ESR: 20 12/28 FIBRINOGEN: 506 12/28 DDIMER: 0.30 12/28 ESR: 27 12/29 FIBRINOGEN: 430 12/29 DDIMER: 0.27 12/29 ESR: 24 12/29 CXR impression: No acute cardiopulmonary disease.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray normal, Cough, Dyspnoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/25, Pfizer, dose #1 04/16, Pfizer, dose #2 11/05, Pfizer, dose #3 12/26 COVID swab, result: detected 12/23 pt cc: cough, fatigue, headache, loss of taste or smell, myalgias, rhinorrhea, sore throat exposure: unknown 12/26 pt medicine cc: cough sob dx: Covid Pneumonia LOS: 4 days APTT 35.2 12/26 SARS-COV-2 Variant Sequencing: pending 12/26 CXR impression: No acute cardiopulmonary disease. 12/26 INR; 1.11 12/26 DDIMER: 0.41 12/26 PT: 12.4 12/26 12/26 BNP: 104.8 12/27 FIBRINOGEN: 596 12/27 DDIMER: 0.26 12/27 PROCALCITONIN: <0.05 12/27 ESR: 20 12/28 FIBRINOGEN: 506 12/28 DDIMER: 0.30 12/28 ESR: 27 12/29 FIBRINOGEN: 430 12/29 DDIMER: 0.27 12/29 ESR: 24 12/29 CXR impression: No acute cardiopulmonary disease.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Fibrin D dimer, Headache, International normalised ratio increased, Myalgia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/25, Pfizer, dose #1 04/16, Pfizer, dose #2 11/05, Pfizer, dose #3 12/26 COVID swab, result: detected 12/23 pt cc: cough, fatigue, headache, loss of taste or smell, myalgias, rhinorrhea, sore throat exposure: unknown 12/26 pt medicine cc: cough sob dx: Covid Pneumonia LOS: 4 days APTT 35.2 12/26 SARS-COV-2 Variant Sequencing: pending 12/26 CXR impression: No acute cardiopulmonary disease. 12/26 INR; 1.11 12/26 DDIMER: 0.41 12/26 PT: 12.4 12/26 12/26 BNP: 104.8 12/27 FIBRINOGEN: 596 12/27 DDIMER: 0.26 12/27 PROCALCITONIN: <0.05 12/27 ESR: 20 12/28 FIBRINOGEN: 506 12/28 DDIMER: 0.30 12/28 ESR: 27 12/29 FIBRINOGEN: 430 12/29 DDIMER: 0.27 12/29 ESR: 24 12/29 CXR impression: No acute cardiopulmonary disease.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Procalcitonin, Prothrombin time normal, Red blood cell sedimentation rate increased, Rhinorrhoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/25, Pfizer, dose #1 04/16, Pfizer, dose #2 11/05, Pfizer, dose #3 12/26 COVID swab, result: detected 12/23 pt cc: cough, fatigue, headache, loss of taste or smell, myalgias, rhinorrhea, sore throat exposure: unknown 12/26 pt medicine cc: cough sob dx: Covid Pneumonia LOS: 4 days APTT 35.2 12/26 SARS-COV-2 Variant Sequencing: pending 12/26 CXR impression: No acute cardiopulmonary disease. 12/26 INR; 1.11 12/26 DDIMER: 0.41 12/26 PT: 12.4 12/26 12/26 BNP: 104.8 12/27 FIBRINOGEN: 596 12/27 DDIMER: 0.26 12/27 PROCALCITONIN: <0.05 12/27 ESR: 20 12/28 FIBRINOGEN: 506 12/28 DDIMER: 0.30 12/28 ESR: 27 12/29 FIBRINOGEN: 430 12/29 DDIMER: 0.27 12/29 ESR: 24 12/29 CXR impression: No acute cardiopulmonary disease.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/25, Pfizer, dose #1 04/16, Pfizer, dose #2 11/05, Pfizer, dose #3 12/26 COVID swab, result: detected 12/23 pt cc: cough, fatigue, headache, loss of taste or smell, myalgias, rhinorrhea, sore throat exposure: unknown 12/26 pt medicine cc: cough sob dx: Covid Pneumonia LOS: 4 days APTT 35.2 12/26 SARS-COV-2 Variant Sequencing: pending 12/26 CXR impression: No acute cardiopulmonary disease. 12/26 INR; 1.11 12/26 DDIMER: 0.41 12/26 PT: 12.4 12/26 12/26 BNP: 104.8 12/27 FIBRINOGEN: 596 12/27 DDIMER: 0.26 12/27 PROCALCITONIN: <0.05 12/27 ESR: 20 12/28 FIBRINOGEN: 506 12/28 DDIMER: 0.30 12/28 ESR: 27 12/29 FIBRINOGEN: 430 12/29 DDIMER: 0.27 12/29 ESR: 24 12/29 CXR impression: No acute cardiopulmonary disease.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Blood fibrinogen normal, C-reactive protein increased, COVID-19, Chest X-ray normal, Cough
Clinical narrative: Narrative:   COVID infection following COVID vaccine series "Unknown date and location when patient took two Pzier vaccine." 12/26 COVID swab, result: detected 12/25 pt cc: fever, n/v, sore throat, myalgias, cough exposure: unknown 12/25 pt admit ED cc: feeling feverish, N/V dx: COVID infection with systemic symptoms LOS: 2 days 12/26 SARS-COV-2 Variant Sequencing: pending 12/26 CXR impression: Negative chest radiograph. 12/26 FIBRINOGEN: 336 12/26 DDIMER: 0.29 12/26 CRP: 5.870 12/27 FIBRINOGEN: 387 12/27 DDIMER: <0.22 12/27 ESR: 18 12/28 FIBRINOGEN: 357 12/28 DDIMER: 024 12/28 ESR: 20
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Myalgia, Nausea, Oropharyngeal pain, Pyrexia
Clinical narrative: Narrative:   COVID infection following COVID vaccine series "Unknown date and location when patient took two Pzier vaccine." 12/26 COVID swab, result: detected 12/25 pt cc: fever, n/v, sore throat, myalgias, cough exposure: unknown 12/25 pt admit ED cc: feeling feverish, N/V dx: COVID infection with systemic symptoms LOS: 2 days 12/26 SARS-COV-2 Variant Sequencing: pending 12/26 CXR impression: Negative chest radiograph. 12/26 FIBRINOGEN: 336 12/26 DDIMER: 0.29 12/26 CRP: 5.870 12/27 FIBRINOGEN: 387 12/27 DDIMER: <0.22 12/27 ESR: 18 12/28 FIBRINOGEN: 357 12/28 DDIMER: 024 12/28 ESR: 20
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Narrative:   COVID infection following COVID vaccine series "Unknown date and location when patient took two Pzier vaccine." 12/26 COVID swab, result: detected 12/25 pt cc: fever, n/v, sore throat, myalgias, cough exposure: unknown 12/25 pt admit ED cc: feeling feverish, N/V dx: COVID infection with systemic symptoms LOS: 2 days 12/26 SARS-COV-2 Variant Sequencing: pending 12/26 CXR impression: Negative chest radiograph. 12/26 FIBRINOGEN: 336 12/26 DDIMER: 0.29 12/26 CRP: 5.870 12/27 FIBRINOGEN: 387 12/27 DDIMER: <0.22 12/27 ESR: 18 12/28 FIBRINOGEN: 357 12/28 DDIMER: 024 12/28 ESR: 20
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient received COVID-19 boost dose 12/6/2021. Patient  with positive COVID test 12/12/2021. Patient remain inpatient from 12/12/2021 until his death on 12/22/2021.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient tested positive for COVID-19 and was hospitalized despite full vaccination and booster. Booster was given on 12/21/2021 and patient was hospitalized with COVID-19 on 01/09/2022
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Headache, Myalgia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/08 Janssen, dose #1 12/27 COVID swab, result: detected 12/27 pt cc: fever, cough, headache, diffuse myalgias, and fatigue exposure: unknown 12/27 pt admit to ED cc: fever, cough, headache, diffuse myalgias, and fatigue DX: Covid - 19 LOS: 1 day 12/30 SARS-COV-2 Variant Sequencing: pending
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/08 Janssen, dose #1 12/27 COVID swab, result: detected 12/27 pt cc: fever, cough, headache, diffuse myalgias, and fatigue exposure: unknown 12/27 pt admit to ED cc: fever, cough, headache, diffuse myalgias, and fatigue DX: Covid - 19 LOS: 1 day 12/30 SARS-COV-2 Variant Sequencing: pending
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient received second COVID vaccine 4/13/2021. Patient admitted to inpatient setting secondary to Positive COVID Pneumonia on 12/15/21 Patient remain in hospital setting until 1/6/21
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: COVID infection following COVID vaccine series 02/04, Pfizer, dose#1 02/25, Pfizer, dose #2 12/27 COVID swab, result: detected 12/25 pt cc: rhinorrhea exposure: unknown
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Fatigue, Inappropriate schedule of product administration
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/30/2020, Pfizer, dose #1 01/21/2021, Pfizer, dose #2 10/18/2021, Pfizer, dose #3 1/2/2022 COVID swab, result: detected 12/26 pt admit ED cc: Cough, chest congestion dx: Acute viral syndrome, COVID-19 LOS: 1 day 12/26 CXR impression: No acute cardiopulmonary findings. 12/23 pt cc: cough, fatigue, myalgias, rhinorrhea exposure: unknown
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive, Viral infection
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/30/2020, Pfizer, dose #1 01/21/2021, Pfizer, dose #2 10/18/2021, Pfizer, dose #3 1/2/2022 COVID swab, result: detected 12/26 pt admit ED cc: Cough, chest congestion dx: Acute viral syndrome, COVID-19 LOS: 1 day 12/26 CXR impression: No acute cardiopulmonary findings. 12/23 pt cc: cough, fatigue, myalgias, rhinorrhea exposure: unknown
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Hypersensitivity, Peripheral swelling, Swelling face
Clinical narrative: Narrative:  ER Course: I examined this patient, after I obtained a history. Given that the patient had some similar symptoms when he had his second dose of his COVID-19 vaccination, it was suspected that his symptoms could be due to an allergic reaction to the vaccine. The patient had already been taken diphenhydramine at home. He was given prednisone 40 mg and famotidine 20 mg in the emergency department. The patient was observed in the emergency department and his eft upper extremity swelling improved and his facial swelling almost completely resolved. The patient also noted that the slight chest tightness he had earlier had resolved. Given that the patient was not having any respiratory symptoms, and that he had significant provement, it was felt that he was stable for discharge and outpatient follow-up
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Oropharyngeal pain, SARS-CoV-2 test positive, Viral infection
Clinical narrative: COVID infection following COVID vaccine series "Refers hx covid vaccines x2" Date & location unknown 1/3 COVID swab result: 1/3 pt cc: sore throat exposure: unknown 12/26 SARS-COV-2 Variant Sequencing: pending 12/26 pt admit ED cc: cough dx: Acute Viral Syndrome, COVID-19 LOS: 1 day
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Death, Plasma cell myeloma
Clinical narrative: Narrative: Patient with multiple myeloma received first Moderna vaccines 2/3/21, 3/3/21 and final shot on 1/3/2022 (died 1/13/2022). Of note pt spent 6 weeks hospitalized with severe COVID Pneumonia around July/August 2021.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine increased, Death, Dialysis, Endotracheal intubation, Haemorrhagic stroke
Clinical narrative: Narrative: Patient received his COVID booster and flu vaccine on 11/5/21. On 11/25/21, he had c/o a severe headache, LUE weakness and was diaphoretic. His  family called EMS and he was taken to a non hospital facility and was intubated and  then transferred to a different facility for a higher level of care for treatment of a  hemorrhagic stroke and hydrocephalus. SCr at this time was 6.10 (not on dialysis  prior to this event but was being evaluated for the need for dialysis). He was  extubated on 11/27/21; however had to be re-intubated on 12/5/21. He did receive  dialysis as well. On 12/10/21, family requested home hospice services as he was  unable to be weaned from the ventilatory and dialysis did not help his neurologic  status. On 12/13/21, he discharge home with home hospice and on 12/15/21 he  passed. There were 40 days from date of vaccine to date of death. No autopsy  reports available.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hydrocephalus, Hyperhidrosis, Mechanical ventilation, Mental disorder
Clinical narrative: Narrative: Patient received his COVID booster and flu vaccine on 11/5/21. On 11/25/21, he had c/o a severe headache, LUE weakness and was diaphoretic. His  family called EMS and he was taken to a non hospital facility and was intubated and  then transferred to a different facility for a higher level of care for treatment of a  hemorrhagic stroke and hydrocephalus. SCr at this time was 6.10 (not on dialysis  prior to this event but was being evaluated for the need for dialysis). He was  extubated on 11/27/21; however had to be re-intubated on 12/5/21. He did receive  dialysis as well. On 12/10/21, family requested home hospice services as he was  unable to be weaned from the ventilatory and dialysis did not help his neurologic  status. On 12/13/21, he discharge home with home hospice and on 12/15/21 he  passed. There were 40 days from date of vaccine to date of death. No autopsy  reports available.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Muscular weakness
Clinical narrative: Narrative: Patient received his COVID booster and flu vaccine on 11/5/21. On 11/25/21, he had c/o a severe headache, LUE weakness and was diaphoretic. His  family called EMS and he was taken to a non hospital facility and was intubated and  then transferred to a different facility for a higher level of care for treatment of a  hemorrhagic stroke and hydrocephalus. SCr at this time was 6.10 (not on dialysis  prior to this event but was being evaluated for the need for dialysis). He was  extubated on 11/27/21; however had to be re-intubated on 12/5/21. He did receive  dialysis as well. On 12/10/21, family requested home hospice services as he was  unable to be weaned from the ventilatory and dialysis did not help his neurologic  status. On 12/13/21, he discharge home with home hospice and on 12/15/21 he  passed. There were 40 days from date of vaccine to date of death. No autopsy  reports available.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient tested positive for COVID-19 on 1/10/2022, received two Pfizer vaccine immunizations, last one on April 28, 2021. No documented booster up to date.
Age: 87.0
Sex: M
Vaccine: TDAP
Symptoms: Guillain-Barre syndrome
Clinical narrative: Narrative:  86 year-old male received Tdap booster shot on 11/9 at clinic. After the shot, he reported he was admitted to Medical Center for a week due to Guillain-Barre syndrome. After discharge from Medical Center, he was in Rehab Center. He was released on 11/27. No documented information information recorded about his hospital stay in Medical Center or Rehab.
Age: 70.0
Sex: M
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/11, Pfizer, dose #1 03/04, Pfizer, dose #2 1/3 COVID swab, result: detected 12/25 pt cc: chills, cough, diarrhea, fever, loss or taste or smell exposure: unknown
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Inappropriate schedule of product administration, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/11, Pfizer, dose #1 03/04, Pfizer, dose #2 1/3 COVID swab, result: detected 12/25 pt cc: chills, cough, diarrhea, fever, loss or taste or smell exposure: unknown
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Inappropriate schedule of product administration
Clinical narrative: Narrative: 94yo male patient with PAST MEDICAL HISTORY (from last MD chart note 7/16/2018), so list is not current. Anemia of chronic renal insufficiency (SChronic atrial fibrillation (SCT 426749004) Congestive heart failure (SCT 42343007) Atrial Fibrillation (ICD-9-CM 427.31) Tobacco user (ICD-9-CM 305.1) Mixed Hearing Loss, unspecified (ICD9- CM 389.20) Arrythmia (ICD-9-CM 427.9) Congestive Heart Failure (ICD-9-CM 428.0) Hypertrophy (Benign) of Prostate withoutErectile Dysfunction (ICD-9-CM 302.72) Anemia (ICD-9-CM 285.9) Mixed conductive and sensorineural hearing loss (ICD-9-CM 389.2) Mixed hyperlipidemia (ICD-9-CM 272.4) HYPERTENSION NOS (ICD-9-CM 401.9) Pt died on 01/02/2022 of unknown causes or circumstances outside of facility hospital. Last chart note in facility from 2/24/2021. Pt had received covid vaccines on 1/21/21 & 2/24/21. Likely pt's death is not related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.
Age: 89.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Arrhythmia, Bradycardia, Brief resolved unexplained event, Cardiac arrest, Circulatory collapse
Clinical narrative: Narrative: 88yr patient received Moderna Booster and Fluad Vaccines on 12/14/21, died on 12/19/21 of cardiac arrest (no autopsy was performed). PMH: Alzheimer's disease, CKD3, aortic sclerosis, afib, dementia, T2DM, HTN, HLD, and bladder cancer. 12/29/2021; patient presented to Facility ED by EMS with increased lethargy, altered mental status (from baseline), and hypotensive (BP 70/45). Physical exam/vitals: PPR: 43, RR 20, BP 77/40, SPO2 87%, CV bradycardic rate, irregular rhythm, diminished pulses. Per outside ER records; patient's was critically ill with a high probability of imminent or life-threatening deterioration (severe sepsis requiring resuscitation (circulatory failure). Patient went into cardiac arrest in the ED and expired.
Age: 89.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Death, Heart rate decreased, Hypotension, Lethargy, Malaise
Clinical narrative: Narrative: 88yr patient received Moderna Booster and Fluad Vaccines on 12/14/21, died on 12/19/21 of cardiac arrest (no autopsy was performed). PMH: Alzheimer's disease, CKD3, aortic sclerosis, afib, dementia, T2DM, HTN, HLD, and bladder cancer. 12/29/2021; patient presented to Facility ED by EMS with increased lethargy, altered mental status (from baseline), and hypotensive (BP 70/45). Physical exam/vitals: PPR: 43, RR 20, BP 77/40, SPO2 87%, CV bradycardic rate, irregular rhythm, diminished pulses. Per outside ER records; patient's was critically ill with a high probability of imminent or life-threatening deterioration (severe sepsis requiring resuscitation (circulatory failure). Patient went into cardiac arrest in the ED and expired.
Age: 89.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Mental status changes, Resuscitation, Sepsis
Clinical narrative: Narrative: 88yr patient received Moderna Booster and Fluad Vaccines on 12/14/21, died on 12/19/21 of cardiac arrest (no autopsy was performed). PMH: Alzheimer's disease, CKD3, aortic sclerosis, afib, dementia, T2DM, HTN, HLD, and bladder cancer. 12/29/2021; patient presented to Facility ED by EMS with increased lethargy, altered mental status (from baseline), and hypotensive (BP 70/45). Physical exam/vitals: PPR: 43, RR 20, BP 77/40, SPO2 87%, CV bradycardic rate, irregular rhythm, diminished pulses. Per outside ER records; patient's was critically ill with a high probability of imminent or life-threatening deterioration (severe sepsis requiring resuscitation (circulatory failure). Patient went into cardiac arrest in the ED and expired.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Apnoea, Bradycardia, Death, Dyspnoea, Dyspnoea exertional
Clinical narrative: Narrative: A 69 year old male presents to ER with complaint of cough, congestion, and difficulty with urination. Patient presents with worsening symptoms for the past 4 days. Patient also has a note with him that was written by his wife. Since Monday, patient reports worsening cough productive of clear sputum, congestion, sore throat, shortness of breath. Patient is on 3 L of oxygen at baseline and reports significant shortness of breath with walking just 15 feet, which he states has been ongoing for the past year. In addition, patient reports difficulty with urination. He states that he only dribbles out small amounts of urine and does not feel like ne IS ever emptying Ins bladder. Of note patient with multiple comorbidities including HFpEF (EF 55-60%), small pericardial effusion, multiple myeloma (diagnosed 2018 off tx since 2019); CKD IV, chronic venous stasis and LE ulcers, DM2, HTN, HLD, CVA, Renal Cell carcinoma s/p right nephrectomy. On 9/6, patient displayed worsening respiratory distress with requirement of Oxymask. Patient was initially transferred to the PCU for HHFNC and placed on 60L 600 0 without notable improvement. Patient was seen by Renal who consented tor tunnel catheter due to poor renal mncüon. With Ins poor renal function and increase oxygen requirements that patient was deemed unstable for Medicine floor and transferred to the MICU for further medical management. Following admission to the MICU pt expressed wishes to transition to comfort measures only. Wife was able to visit and with full decision making capacity the patient opted for CMO. Palliative care was consulted, pt known to them. He was started on comfort pain ativan, bowel regimen. As pt was about to be transferred to medicine floor he became apneic and bradycardic and passed at 10:45am.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dysuria, Intensive care, Oropharyngeal pain, Productive cough, Renal impairment
Clinical narrative: Narrative: A 69 year old male presents to ER with complaint of cough, congestion, and difficulty with urination. Patient presents with worsening symptoms for the past 4 days. Patient also has a note with him that was written by his wife. Since Monday, patient reports worsening cough productive of clear sputum, congestion, sore throat, shortness of breath. Patient is on 3 L of oxygen at baseline and reports significant shortness of breath with walking just 15 feet, which he states has been ongoing for the past year. In addition, patient reports difficulty with urination. He states that he only dribbles out small amounts of urine and does not feel like ne IS ever emptying Ins bladder. Of note patient with multiple comorbidities including HFpEF (EF 55-60%), small pericardial effusion, multiple myeloma (diagnosed 2018 off tx since 2019); CKD IV, chronic venous stasis and LE ulcers, DM2, HTN, HLD, CVA, Renal Cell carcinoma s/p right nephrectomy. On 9/6, patient displayed worsening respiratory distress with requirement of Oxymask. Patient was initially transferred to the PCU for HHFNC and placed on 60L 600 0 without notable improvement. Patient was seen by Renal who consented tor tunnel catheter due to poor renal mncüon. With Ins poor renal function and increase oxygen requirements that patient was deemed unstable for Medicine floor and transferred to the MICU for further medical management. Following admission to the MICU pt expressed wishes to transition to comfort measures only. Wife was able to visit and with full decision making capacity the patient opted for CMO. Palliative care was consulted, pt known to them. He was started on comfort pain ativan, bowel regimen. As pt was about to be transferred to medicine floor he became apneic and bradycardic and passed at 10:45am.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Respiratory distress, Respiratory tract congestion, Urinary retention, Urine output decreased
Clinical narrative: Narrative: A 69 year old male presents to ER with complaint of cough, congestion, and difficulty with urination. Patient presents with worsening symptoms for the past 4 days. Patient also has a note with him that was written by his wife. Since Monday, patient reports worsening cough productive of clear sputum, congestion, sore throat, shortness of breath. Patient is on 3 L of oxygen at baseline and reports significant shortness of breath with walking just 15 feet, which he states has been ongoing for the past year. In addition, patient reports difficulty with urination. He states that he only dribbles out small amounts of urine and does not feel like ne IS ever emptying Ins bladder. Of note patient with multiple comorbidities including HFpEF (EF 55-60%), small pericardial effusion, multiple myeloma (diagnosed 2018 off tx since 2019); CKD IV, chronic venous stasis and LE ulcers, DM2, HTN, HLD, CVA, Renal Cell carcinoma s/p right nephrectomy. On 9/6, patient displayed worsening respiratory distress with requirement of Oxymask. Patient was initially transferred to the PCU for HHFNC and placed on 60L 600 0 without notable improvement. Patient was seen by Renal who consented tor tunnel catheter due to poor renal mncüon. With Ins poor renal function and increase oxygen requirements that patient was deemed unstable for Medicine floor and transferred to the MICU for further medical management. Following admission to the MICU pt expressed wishes to transition to comfort measures only. Wife was able to visit and with full decision making capacity the patient opted for CMO. Palliative care was consulted, pt known to them. He was started on comfort pain ativan, bowel regimen. As pt was about to be transferred to medicine floor he became apneic and bradycardic and passed at 10:45am.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Transient ischaemic attack
Clinical narrative: Narrative:  reported TIA 2-3 days after vaccine administration
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cerebrovascular accident, Nasal congestion, SARS-CoV-2 test positive
Clinical narrative: Pt was on 4J as inpatient for rehab post stroke when he contracted COVID due to outbreak on the unit. He was transferred to 3E for isolation. Ver had mild nasal congestion the day he was diagnosed, but was otherwise asymptomatic throughout his COVID course. He did receive Cas/Imde mabs, and was later transferred back to 4J reinstate rehabilitated.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pollakiuria
Clinical narrative: 70-year old female with a PMH of T2DM (on empagliflozin) received her booster on 10/1/2021. She experienced frequent urination right after getting the vaccines in medical facility. No further details documented in patient notes.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Narrative:
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased, Dysphagia
Clinical narrative: Narrative:  Pt states that shortly after receiving vaccine, his blood sugar went to 500-600's, which is unusual for him. He was hospitalized overnight and was treated. Patient also states that he started having difficulty swallowing following the vaccine.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Pt under Hospice for Lewy Body Dementia
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Fatigue, Headache
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/30, Pfizer, dose #1 (private sector- Orange CHD) 05/21, Pfizer, dose #2 (private sector- Orange CHD) 12/25 COVID swab, result: detected 12/25 pt cc: chills, cough, fatigue, fever, headache, myalgias, rhinorrhea, sore throat exposure: unknown 12/25 pt admit ED cc: "Cough congestion nasal congestion sore throat" dx: COVID positive LOS: 1 day 12/25 SARS-COV-2 Variant Sequencing: pending 1/3/22 clinically resolved
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nasal congestion, Oropharyngeal pain, Pyrexia, Respiratory tract congestion
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/30, Pfizer, dose #1 (private sector- Orange CHD) 05/21, Pfizer, dose #2 (private sector- Orange CHD) 12/25 COVID swab, result: detected 12/25 pt cc: chills, cough, fatigue, fever, headache, myalgias, rhinorrhea, sore throat exposure: unknown 12/25 pt admit ED cc: "Cough congestion nasal congestion sore throat" dx: COVID positive LOS: 1 day 12/25 SARS-COV-2 Variant Sequencing: pending 1/3/22 clinically resolved
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/30, Pfizer, dose #1 (private sector- Orange CHD) 05/21, Pfizer, dose #2 (private sector- Orange CHD) 12/25 COVID swab, result: detected 12/25 pt cc: chills, cough, fatigue, fever, headache, myalgias, rhinorrhea, sore throat exposure: unknown 12/25 pt admit ED cc: "Cough congestion nasal congestion sore throat" dx: COVID positive LOS: 1 day 12/25 SARS-COV-2 Variant Sequencing: pending 1/3/22 clinically resolved
Age: 86.0
Sex: M
Vaccine: FLU4
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 70.0
Sex: M
Vaccine: PPV
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Dyspnoea, Fatigue, Headache
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/09, Pfizer, dose #1 04/01, Pfizer, dose #2 11/23, Pfizer, dose #3 08/08 COVID swab, result: NOT detected 12/27 COVID swab, result: detected 12/25 pt cc: chills, cough, fatigue, fever, headache, myalgias, nausea, rhinorrhea, dyspnea, sore throat exposure: unknown 1/1 clinically resolved
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Oropharyngeal pain, Pyrexia, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/09, Pfizer, dose #1 04/01, Pfizer, dose #2 11/23, Pfizer, dose #3 08/08 COVID swab, result: NOT detected 12/27 COVID swab, result: detected 12/25 pt cc: chills, cough, fatigue, fever, headache, myalgias, nausea, rhinorrhea, dyspnea, sore throat exposure: unknown 1/1 clinically resolved
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/09, Pfizer, dose #1 04/01, Pfizer, dose #2 11/23, Pfizer, dose #3 08/08 COVID swab, result: NOT detected 12/27 COVID swab, result: detected 12/25 pt cc: chills, cough, fatigue, fever, headache, myalgias, nausea, rhinorrhea, dyspnea, sore throat exposure: unknown 1/1 clinically resolved
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  97yo male patient with PROBLEM LIST: (from last MD note on 9/19/2011): Abnormal Liver Function Tests (ICD-9-CM Allergies (ICD-9-CM 995.3) Memory loss (ICD-9-CM 780.93) URI (ICD-9-CM 465.9) Pt died on 12/25/2021 cause is unknown. Last chart note on 3/19/2021. Pt received covid vaccines on 2/19/2021 & 3/19/2021. Likely pt's death is not related to covid vaccines given pt's advanced age and long length of time between death & date of vaccine administrations.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Blood lactic acid, COVID-19, Chest X-ray normal, Cough
Clinical narrative: Narrative: Admitted: JAN 14,2022 Primary diagnosis during this hospitalization. COVID19 62yo male with tobacco use, hx GI bleed, and locally advanced squamous cell carcinoma of L hypopharynx currently on chemo/XRT presenting to Emergency Dept (ED) with fever, cough, n/v. Patient reports symptoms starting 1/7/22. Cough wit minimal sputum production. Nausea with several episodes of vomiting each day. Also sore throat. Had friend that stayed with him over weekend with similar symptoms. Denies CP, SOB, diarrhea, abdominal pain. Was getting XRT Mon-Friday, last treatment the day prior to Emergency Dept visit. COVID vaccinated x2 May/June 2021. In the ED, temp 103.3, HR 121, BP 114/83, O2 sat 95% on RA. Labs notable for WBC 5.6, Hgb 10.7 BMP unremarkable. Lactate 1.48, trop negative. UA without signs of infection. COVID PCR positive. CXR neg for acute process. Patient was admitted. HOSPITAL COURSE BY PROBLEM: #Fever/COVID:  Patient presented with worsening cough, fever, nausea/vomiting, found to be COVID positive on 1/11/22. Stable on RA, no respiratory symptoms. CXR clear. Treated with one time dose of sotrovimab 1/12/22. Oncology was consulted, recommended holding empire abx for now pending cultures. Was treated with anticoagulation with lovenox 60mg BID. Fevers improved over several days with Tmax 99.8 day prior to discharge. Nausea/vomitng: likely secondary to COVID. Treated with PRN Zofran while inpatient, continued outpatient at discharge.  #Cough/#Sore throat:  Likely secondary to COVID19 infection. Treated with dextrimethorphan/guaifenesin and chloraseptic throat spray. Symptoms improving at discharge. CONDITION ON DISCHARGE: stable DISPOSITION: Home
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Haemoglobin decreased, Influenza A virus test negative, Influenza B virus test, Metabolic function test normal, Nausea
Clinical narrative: Narrative: Admitted: JAN 14,2022 Primary diagnosis during this hospitalization. COVID19 62yo male with tobacco use, hx GI bleed, and locally advanced squamous cell carcinoma of L hypopharynx currently on chemo/XRT presenting to Emergency Dept (ED) with fever, cough, n/v. Patient reports symptoms starting 1/7/22. Cough wit minimal sputum production. Nausea with several episodes of vomiting each day. Also sore throat. Had friend that stayed with him over weekend with similar symptoms. Denies CP, SOB, diarrhea, abdominal pain. Was getting XRT Mon-Friday, last treatment the day prior to Emergency Dept visit. COVID vaccinated x2 May/June 2021. In the ED, temp 103.3, HR 121, BP 114/83, O2 sat 95% on RA. Labs notable for WBC 5.6, Hgb 10.7 BMP unremarkable. Lactate 1.48, trop negative. UA without signs of infection. COVID PCR positive. CXR neg for acute process. Patient was admitted. HOSPITAL COURSE BY PROBLEM: #Fever/COVID:  Patient presented with worsening cough, fever, nausea/vomiting, found to be COVID positive on 1/11/22. Stable on RA, no respiratory symptoms. CXR clear. Treated with one time dose of sotrovimab 1/12/22. Oncology was consulted, recommended holding empire abx for now pending cultures. Was treated with anticoagulation with lovenox 60mg BID. Fevers improved over several days with Tmax 99.8 day prior to discharge. Nausea/vomitng: likely secondary to COVID. Treated with PRN Zofran while inpatient, continued outpatient at discharge.  #Cough/#Sore throat:  Likely secondary to COVID19 infection. Treated with dextrimethorphan/guaifenesin and chloraseptic throat spray. Symptoms improving at discharge. CONDITION ON DISCHARGE: stable DISPOSITION: Home
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal pain, Productive cough, Pyrexia, Radiotherapy, Respiratory syncytial virus test negative
Clinical narrative: Narrative: Admitted: JAN 14,2022 Primary diagnosis during this hospitalization. COVID19 62yo male with tobacco use, hx GI bleed, and locally advanced squamous cell carcinoma of L hypopharynx currently on chemo/XRT presenting to Emergency Dept (ED) with fever, cough, n/v. Patient reports symptoms starting 1/7/22. Cough wit minimal sputum production. Nausea with several episodes of vomiting each day. Also sore throat. Had friend that stayed with him over weekend with similar symptoms. Denies CP, SOB, diarrhea, abdominal pain. Was getting XRT Mon-Friday, last treatment the day prior to Emergency Dept visit. COVID vaccinated x2 May/June 2021. In the ED, temp 103.3, HR 121, BP 114/83, O2 sat 95% on RA. Labs notable for WBC 5.6, Hgb 10.7 BMP unremarkable. Lactate 1.48, trop negative. UA without signs of infection. COVID PCR positive. CXR neg for acute process. Patient was admitted. HOSPITAL COURSE BY PROBLEM: #Fever/COVID:  Patient presented with worsening cough, fever, nausea/vomiting, found to be COVID positive on 1/11/22. Stable on RA, no respiratory symptoms. CXR clear. Treated with one time dose of sotrovimab 1/12/22. Oncology was consulted, recommended holding empire abx for now pending cultures. Was treated with anticoagulation with lovenox 60mg BID. Fevers improved over several days with Tmax 99.8 day prior to discharge. Nausea/vomitng: likely secondary to COVID. Treated with PRN Zofran while inpatient, continued outpatient at discharge.  #Cough/#Sore throat:  Likely secondary to COVID19 infection. Treated with dextrimethorphan/guaifenesin and chloraseptic throat spray. Symptoms improving at discharge. CONDITION ON DISCHARGE: stable DISPOSITION: Home
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Troponin normal, Urine analysis normal, Vomiting, White blood cell count normal
Clinical narrative: Narrative: Admitted: JAN 14,2022 Primary diagnosis during this hospitalization. COVID19 62yo male with tobacco use, hx GI bleed, and locally advanced squamous cell carcinoma of L hypopharynx currently on chemo/XRT presenting to Emergency Dept (ED) with fever, cough, n/v. Patient reports symptoms starting 1/7/22. Cough wit minimal sputum production. Nausea with several episodes of vomiting each day. Also sore throat. Had friend that stayed with him over weekend with similar symptoms. Denies CP, SOB, diarrhea, abdominal pain. Was getting XRT Mon-Friday, last treatment the day prior to Emergency Dept visit. COVID vaccinated x2 May/June 2021. In the ED, temp 103.3, HR 121, BP 114/83, O2 sat 95% on RA. Labs notable for WBC 5.6, Hgb 10.7 BMP unremarkable. Lactate 1.48, trop negative. UA without signs of infection. COVID PCR positive. CXR neg for acute process. Patient was admitted. HOSPITAL COURSE BY PROBLEM: #Fever/COVID:  Patient presented with worsening cough, fever, nausea/vomiting, found to be COVID positive on 1/11/22. Stable on RA, no respiratory symptoms. CXR clear. Treated with one time dose of sotrovimab 1/12/22. Oncology was consulted, recommended holding empire abx for now pending cultures. Was treated with anticoagulation with lovenox 60mg BID. Fevers improved over several days with Tmax 99.8 day prior to discharge. Nausea/vomitng: likely secondary to COVID. Treated with PRN Zofran while inpatient, continued outpatient at discharge.  #Cough/#Sore throat:  Likely secondary to COVID19 infection. Treated with dextrimethorphan/guaifenesin and chloraseptic throat spray. Symptoms improving at discharge. CONDITION ON DISCHARGE: stable DISPOSITION: Home
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Aortic arteriosclerosis, Atelectasis, Blood lactic acid increased, COVID-19
Clinical narrative: Narrative:  Admitted: JAN 8,2022 Discharged: Jan 14,2022 85 y/o M with PMH BPH, HLD, HTN, dementia, insomnia, b/l hearing loss, CKD, COPD (2018 via CT w/ emphysema), seizure, stroke/meningioma, blind secondary to glaucoma and cataracts presented to the Emergency Department with altered mental status, acute hypoxic respiratory failure, COVID+ despite vaccination x 2 and required ICU care. #Acute hypoxic respiratory failure, Covid positive, h/o COPD (improving): On admission on 1/8/22 patient tested positive for COVID and was febrile with a procalcitonin of 4. Patient initially requiring 4 L nasal cannula in ED. Started on CAP coverage in ED, ceftriaxone and azithromycin. Given concern for sepsis, patient required ICU care. He was broadened out from CAP to Vanc/Zosyn; Remdesevir, Dexamethasone 6mg daily. Infectious workup done and was negative aside from pulmonary source. Patient showed improvement with downtrend in lactate and was weaned to Room Air. He was then transferred to floor and transitioned back to ceftriaxone and azithromycin. He completed 7 day course of antibiotics, 5 days of remdesivir, and 10 days of dexamethsone 6mg daily. Discharged in stable condition.
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardioversion, Chest X-ray abnormal, Chronic obstructive pulmonary disease, Condition aggravated, Intensive care
Clinical narrative: Narrative:  Admitted: JAN 8,2022 Discharged: Jan 14,2022 85 y/o M with PMH BPH, HLD, HTN, dementia, insomnia, b/l hearing loss, CKD, COPD (2018 via CT w/ emphysema), seizure, stroke/meningioma, blind secondary to glaucoma and cataracts presented to the Emergency Department with altered mental status, acute hypoxic respiratory failure, COVID+ despite vaccination x 2 and required ICU care. #Acute hypoxic respiratory failure, Covid positive, h/o COPD (improving): On admission on 1/8/22 patient tested positive for COVID and was febrile with a procalcitonin of 4. Patient initially requiring 4 L nasal cannula in ED. Started on CAP coverage in ED, ceftriaxone and azithromycin. Given concern for sepsis, patient required ICU care. He was broadened out from CAP to Vanc/Zosyn; Remdesevir, Dexamethasone 6mg daily. Infectious workup done and was negative aside from pulmonary source. Patient showed improvement with downtrend in lactate and was weaned to Room Air. He was then transferred to floor and transitioned back to ceftriaxone and azithromycin. He completed 7 day course of antibiotics, 5 days of remdesivir, and 10 days of dexamethsone 6mg daily. Discharged in stable condition.
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Mental status changes, Pneumonia, Procalcitonin, Pulmonary congestion
Clinical narrative: Narrative:  Admitted: JAN 8,2022 Discharged: Jan 14,2022 85 y/o M with PMH BPH, HLD, HTN, dementia, insomnia, b/l hearing loss, CKD, COPD (2018 via CT w/ emphysema), seizure, stroke/meningioma, blind secondary to glaucoma and cataracts presented to the Emergency Department with altered mental status, acute hypoxic respiratory failure, COVID+ despite vaccination x 2 and required ICU care. #Acute hypoxic respiratory failure, Covid positive, h/o COPD (improving): On admission on 1/8/22 patient tested positive for COVID and was febrile with a procalcitonin of 4. Patient initially requiring 4 L nasal cannula in ED. Started on CAP coverage in ED, ceftriaxone and azithromycin. Given concern for sepsis, patient required ICU care. He was broadened out from CAP to Vanc/Zosyn; Remdesevir, Dexamethasone 6mg daily. Infectious workup done and was negative aside from pulmonary source. Patient showed improvement with downtrend in lactate and was weaned to Room Air. He was then transferred to floor and transitioned back to ceftriaxone and azithromycin. He completed 7 day course of antibiotics, 5 days of remdesivir, and 10 days of dexamethsone 6mg daily. Discharged in stable condition.
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulmonary vascular disorder, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Admitted: JAN 8,2022 Discharged: Jan 14,2022 85 y/o M with PMH BPH, HLD, HTN, dementia, insomnia, b/l hearing loss, CKD, COPD (2018 via CT w/ emphysema), seizure, stroke/meningioma, blind secondary to glaucoma and cataracts presented to the Emergency Department with altered mental status, acute hypoxic respiratory failure, COVID+ despite vaccination x 2 and required ICU care. #Acute hypoxic respiratory failure, Covid positive, h/o COPD (improving): On admission on 1/8/22 patient tested positive for COVID and was febrile with a procalcitonin of 4. Patient initially requiring 4 L nasal cannula in ED. Started on CAP coverage in ED, ceftriaxone and azithromycin. Given concern for sepsis, patient required ICU care. He was broadened out from CAP to Vanc/Zosyn; Remdesevir, Dexamethasone 6mg daily. Infectious workup done and was negative aside from pulmonary source. Patient showed improvement with downtrend in lactate and was weaned to Room Air. He was then transferred to floor and transitioned back to ceftriaxone and azithromycin. He completed 7 day course of antibiotics, 5 days of remdesivir, and 10 days of dexamethsone 6mg daily. Discharged in stable condition.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/04, Pfizer, dose #1 02/25, Pfizer, dose #2 12/27 COVID swab, result: detected 12/27 pt cc: exposure: unknown
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Oropharyngeal pain, Pain
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/08, Pfizer, dose #1 01/29, Pfizer, dose #2 12/28 COVID swab, result: detected 12/26 pt cc: cough, fatigue, body aches, low grade fever, sore throat, and coughing exposure: unknown 12/28 pt admit ED cc: body aches, low grade fever, sore throat, and coughing dx: COVID19 LOS: 1 day 12/31 clinically resolved
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/08, Pfizer, dose #1 01/29, Pfizer, dose #2 12/28 COVID swab, result: detected 12/26 pt cc: cough, fatigue, body aches, low grade fever, sore throat, and coughing exposure: unknown 12/28 pt admit ED cc: body aches, low grade fever, sore throat, and coughing dx: COVID19 LOS: 1 day 12/31 clinically resolved
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/11, MODERNA, dose #1 (NON-CLINIC) 02/08, MODERNA, dose #2(NON-CLINIC) 12/28 COVID swab, result: detected 12/27 pt cc: chills, fatigue, fever, headache, loss of taste or smell, dyspnea exposure: unknown 12/28 pt admit ED cc: sore throat, fever, nonproductive cough dx: COVID-19 LOS: 1 day
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Headache, Oropharyngeal pain, Pyrexia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/11, MODERNA, dose #1 (NON-CLINIC) 02/08, MODERNA, dose #2(NON-CLINIC) 12/28 COVID swab, result: detected 12/27 pt cc: chills, fatigue, fever, headache, loss of taste or smell, dyspnea exposure: unknown 12/28 pt admit ED cc: sore throat, fever, nonproductive cough dx: COVID-19 LOS: 1 day
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/11, MODERNA, dose #1 (NON-CLINIC) 02/08, MODERNA, dose #2(NON-CLINIC) 12/28 COVID swab, result: detected 12/27 pt cc: chills, fatigue, fever, headache, loss of taste or smell, dyspnea exposure: unknown 12/28 pt admit ED cc: sore throat, fever, nonproductive cough dx: COVID-19 LOS: 1 day
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Fear, Inappropriate schedule of product administration
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/02, Moderna , dose #1 04/29, Moderna , dose #2 12/27 COVID swab, result: detected 12/26 pt cc: cough, diarrhea, fever, rhinorrhea exposure: unknown
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/02, Moderna , dose #1 04/29, Moderna , dose #2 12/27 COVID swab, result: detected 12/26 pt cc: cough, diarrhea, fever, rhinorrhea exposure: unknown
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/05, Janssen , dose #1 12/22, Pfizer, dose #2 12/27 COVID swab, result: detected 12/27 pt cc: exposure: unknown
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient tested positive for COVID-19 and was hospitalized despite full vaccination of Moderna dose 1 and 2. Dose 2 on 03/10/2021, with no booster documented up to date.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 79yo male patient who had not received medical care since 2013 died on 1/5/2022 of unknown cause. Pt had received a covid vaccine on 1/14/2021. Likely pt's death is not related to covid vaccines given pt's advanced age and long length of time between death & date of vaccine administrations.